Dr. Simon is an experienced CMC and pharmaceutical development leader with expertise spanning formulation, analytical development, manufacturing, GMP operations, and regulatory strategy. He helps pharmaceutical and biotechnology companies navigate CMC requirements and advance development programs toward regulatory milestones.
His career includes leadership roles in CMC, GMP, analytical development, and formulation at the University of Florida, PharmaLex, CoreRx Pharmaceuticals, and Nitto Avecia Pharmaceutical Services. His experience encompasses radiopharmaceuticals, small molecules, immunotherapeutics, lipid nanoparticle products, and oral solid and liquid dosage forms.
Dr. Simon has led CMC activities across multiple development programs, authored and reviewed CMC Module 3 documentation, conducted gap assessments, supported IND submissions and FDA interactions, and established GMP processes and quality systems. He brings a practical approach to helping clients assess risk, strengthen regulatory readiness, and move programs efficiently through development.
Dr. Simon holds a PhD in Organometallic Chemistry from Pontificia Universidad Católica de Chile and a Master of Science in Nuclear Chemistry from Saint Petersburg State University. He also completed postdoctoral research in Organometallic Chemistry at the University of California, San Diego.